3/22/2019 Investorplace.com   Share to Facebook  Share on Google+  

7 Marijuana Stocks to Play the CBD Trend


7 Marijuana Stocks to Play the CBD TrendCannabidiol (CBD) is emerging as a red-hot category of the marijuana industry. CBD includes compounds in the cannabis sativa plant that do not produce a high. In fact, over the years, CBDs have been shown to have powerful therapeutic effects. Now it looks like the U.S. market could open up in a big way for this type of cannabis and several CBD stocks are gaining traction. The reason: In December, Congress passed the 2018 Farm Bill, which declared that CBD would no longer be treated as an illegal substance. So how big could this opportunity be?  Well, according to research from the Brightfield Group, the market in the U.S. could hit $22 billion by 2022. No doubt, this could move the needle for marijuana stocks — and here’s a look at seven that stand out: Compare Brokers Cronos Group (CRON) Cronos Group (NYSE:CRON) operates a vertically integrated cannabis platform, with a presence across five continents. In terms of the CBD opportunity, the company recently struck a strategic partnership with Gingko Bioworks, which has raised $430 million. The company’s founder, Tom Knight, is known as the “father of synthetic biology” and his innovations — such as with software to print DNA — should allow for the creation of cannabinoids at a massive scale. This is critical because it can be difficult to produce pure forms that are cost-effective and precise. CRON also has the advantage of substantial financial resources to commercialize its cannabinoids. Last December, Altria (NYSE:MO) invested $1.8 billion into



Read More